hcrispra v2 (Addgene inc)
Addgene inc is a verified supplier 
94
Structured Review
Addgene inc
hcrispra v2
Hcrispra V2, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 28 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hcrispra+v2/Human+Genome-wide+CRISPRa-v2+Libraries+(Pooled+Libraries+%2383978%2C+%231000000091)/pm41898529-174-18-17
Average 94 stars, based on 28 article reviews
Hcrispra V2, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 28 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hcrispra+v2/Human+Genome-wide+CRISPRa-v2+Libraries+(Pooled+Libraries+%2383978%2C+%231000000091)/pm41898529-174-18-17
Average 94 stars, based on 28 article reviews
hcrispra v2 - by Bioz Stars,
2026-09
94/100 stars
Images
Related Articles
Recombinant:Article Title: A curative combination cancer therapy achieves high fractional cell killing through low cross-resistance and drug additivity Article Snippet: Recombinant DNA reagent , hCRISPRi_v2 , Addgene (Cat#83969 and 83970) , RRID: Addgene_83969 , Genome-wide human library of sgRNAs for CRISPRi. .. Recombinant DNA reagent , Genome Wide:Article Title: A curative combination cancer therapy achieves high fractional cell killing through low cross-resistance and drug additivity Article Snippet: Recombinant DNA reagent , hCRISPRi_v2 , Addgene (Cat#83969 and 83970) , RRID: Addgene_83969 , Genome-wide human library of sgRNAs for CRISPRi. .. Recombinant DNA reagent , Article Title: Genome-Wide CRISPR Screens Identify ABCG2-Mediated Drug Resistance to the Threonine Tyrosine Kinase (TTK) Inhibitor CFI-402257 in Breast Cancer. Article Snippet: .. The Weissman genome-wide CRISPR activation (CRISPRa) library containing 104,540 sgRNAs targeting 19,915 human genes was obtained from Addgene ( Article Title: Genome-Wide CRISPR Screens Identify ABCG2-Mediated Drug Resistance to the Threonine Tyrosine Kinase (TTK) Inhibitor CFI-402257 in Breast Cancer Article Snippet: .. The Weissman genome-wide CRISPR activation (CRISPRa) library containing 104,540 sgRNAs targeting 19,915 human genes was obtained from Addgene ( Virus:Article Title: CRISPRi/a screens in human iPSC-cardiomyocytes identify glycolytic activation as a druggable target for doxorubicin-induced cardiotoxicity. Article Snippet: Article Negative Control:Article Title: CRISPRi/a screens in human iPSC-cardiomyocytes identify glycolytic activation as a druggable target for doxorubicin-induced cardiotoxicity. Article Snippet: Article CRISPR:Article Title: Genome-Wide CRISPR Screens Identify ABCG2-Mediated Drug Resistance to the Threonine Tyrosine Kinase (TTK) Inhibitor CFI-402257 in Breast Cancer. Article Snippet: .. The Weissman genome-wide CRISPR activation (CRISPRa) library containing 104,540 sgRNAs targeting 19,915 human genes was obtained from Addgene ( Article Title: Genome-Wide CRISPR Screens Identify ABCG2-Mediated Drug Resistance to the Threonine Tyrosine Kinase (TTK) Inhibitor CFI-402257 in Breast Cancer Article Snippet: .. The Weissman genome-wide CRISPR activation (CRISPRa) library containing 104,540 sgRNAs targeting 19,915 human genes was obtained from Addgene ( Activation Assay:Article Title: Genome-Wide CRISPR Screens Identify ABCG2-Mediated Drug Resistance to the Threonine Tyrosine Kinase (TTK) Inhibitor CFI-402257 in Breast Cancer. Article Snippet: .. The Weissman genome-wide CRISPR activation (CRISPRa) library containing 104,540 sgRNAs targeting 19,915 human genes was obtained from Addgene ( Article Title: Genome-Wide CRISPR Screens Identify ABCG2-Mediated Drug Resistance to the Threonine Tyrosine Kinase (TTK) Inhibitor CFI-402257 in Breast Cancer Article Snippet: .. The Weissman genome-wide CRISPR activation (CRISPRa) library containing 104,540 sgRNAs targeting 19,915 human genes was obtained from Addgene ( |